Validation of the equations for estimating daily sodium excretion from spot urine in patients with chronic kidney disease
- 696 Downloads
Measuring sodium excretion in a 24-h urine collection is the most reliable method of estimating salt intake, but it is not applicable to all patients. As an alternative, equations for estimating Na excretion from Japanese by a spot urine sample were created, but they have not been validated in patients with chronic kidney disease (CKD), which are frequently associated with nocturia and medication.
We enrolled 136 patients with CKD and collected both 24-h urine and the first morning urine. Na excretion was estimated from the first morning urine by Kawasaki’s equation, which was originally used for the second morning urine, and Tanaka’s equation, which is applied for spot urine samples taken at any time from 9 am to 7 pm. We evaluated the two equations for bias, RMSE and accuracy within 30 and 50% of the measured Na excretion.
Bias, RMSE and accuracy within 30% of the estimated Na excretion were 48 ± 69 and 2 ± 69 mmol/day, 84 and 69 mmol/day, and 35 and 49% using Kawasaki’s equation and Tanaka’s equation, respectively. Na excretion in the first morning urine was accurately estimated by Tanaka’s equation, but it was overestimated by Kawasaki’s equation. Nocturia and medication such as diuretics and ACE inhibitor or angiotensin receptor blocker did not affect the accuracy with which Na excretion was estimated by Tanaka’s equation substantially.
Tanaka’s equation for estimating Na excretion from the first morning urine in patients with CKD is accurate enough for use in clinical practice.
KeywordsSodium Creatinine CKD Estimated Na excretion
This study was supported by a grant from the Ministry of Health, Labor and Welfare.
- 2.Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ. 2007;334(7599):885–8.PubMedCrossRefGoogle Scholar
- 3.Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ. 1988;297(6644):319–28.Google Scholar
- 4.Hooper L, Bartlett C, Davey Smith G, Ebrahim S. Reduced dietary salt for prevention of cardiovascular disease. Cochrane Database Syst Rev. 2003;3:CD003656.Google Scholar
- 6.The Japanese Society of Hypertension. Guidelines (JSH 2009). Chapter 4: lifestyle modifications. Hypertens Res. 2009;32:29–32.Google Scholar
- 7.Kawano Y, Tsuchihashi T, Matsuura H, Ando K, Fujita T, Ueshima H. Report of the Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension. 2. Assessment of salt intake in the management of hypertension. Hypertens Res. 2007;30(10):887–93.Google Scholar
- 15.Tamaki J, Kikuchi Y, Yoshita K, Takebayashi T, Chiba N, Tanaka T, Okamura T, Kasagi F, Minai J, Ueshima H. Stages of change for salt intake and urinary salt excretion: baseline results from the High-Risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) study. Hypertens Res. 2004;27(3):157–66.PubMedCrossRefGoogle Scholar
- 20.Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res. 2009;32(1):3–107.PubMedCrossRefGoogle Scholar
- 21.Japanese Society of Nephrology. Evidence-based practice guideline for the treatment of CKD. Clin Exp Nephrol. 2009;13(6):537–66.Google Scholar